Evolution of extended-spectrum beta-lactamases by mutation.
about
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by HalogensEvolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistanceNetwork models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectoriesOrigins and evolution of antibiotic resistanceEnhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.SHV Lactamase Engineering Database: a reconciliation tool for SHV β-lactamases in public databases.Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates.Characterization of two new CTX-M-25-group extended-spectrum β-lactamase variants identified in Escherichia coli isolates from Israel.Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands.Trends in serotype distribution and antimicrobial susceptibility in Salmonella enterica isolates from humans in Belgium, 2009 to 2013.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.The class A β-lactamase FTU-1 is native to Francisella tularensis.Antagonistic Coevolution Drives Whack-a-Mole Sensitivity in Gene Regulatory NetworksCharacteristics of extended-spectrum β-lactamase-producing Escherichia coli isolated from fecal samples of piglets with diarrhea in central and southern Taiwan in 2015A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.Diversity of immune strategies explained by adaptation to pathogen statistics.Multiresistant Enterobacteriaceae: new threat of an old problem.Molecular characterization and in silico analysis of naturally occurring TEM beta-lactamase variants among pathogenic Enterobacteriaceae infecting Indian patients.Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance.Identification of beta-Lactamases and beta-Lactam-Related Proteins in Human Pathogenic Bacteria using a Computational Search Approach.Types and prevalence of extended-spectrum beta-lactamase producing Enterobacteriaceae in poultry.Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Casablanca.Antibacterial Activity of Some Plant Extracts Against Extended- Spectrum Beta-Lactamase Producing Escherichia coli IsolatesMutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.Multidrug-resistant phenotype and isolation of a novel SHV- beta-Lactamase variant in a clinical isolate of Enterobacter cloacae.Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genesDevelopment and evaluation of a novel universal β-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli.Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTIn vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.CTX-M-15-producing Shigella sonnei strain from a Czech patient who traveled in Asia.BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals[Evolutionary explanation of the diversity of immune strategies].High rates of susceptibility to ceftazidime among globally prevalent CTX-M-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.Amperometric detection of extended-spectrum β-lactamase activity: application to the characterization of resistant E. coli strains.Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance
P2860
Q27700611-A16D23C5-6C15-4EC8-8756-ADDD6D7E5FEBQ28472615-C6F7B9F4-149C-4238-A19B-2C3815ABAADBQ28477196-EACCE2AE-3117-4BB5-9994-E9BEBA56E802Q29617791-193AD540-F9B2-4F83-97BF-9E1F51A50A5DQ33601560-FEB5AB06-9A85-4550-9D75-947B4D27CF8CQ33717421-8CFF7CA7-D946-4898-BCED-4C6DE995A14AQ33963663-E475FE32-C5D7-46B5-90CA-C864144DE92BQ34438766-9D6D32E7-1D00-4202-A88F-E6DD0DEC0C36Q34532991-2977E42F-1886-49C6-98E8-2A3D66AA4C80Q34922895-7499F8B5-B497-4336-8057-54104D9C0BCFQ35297743-807DEFCA-95B3-420A-AAF8-0CD6C7BCBD7CQ35689231-D2626222-CCC0-482A-AF8D-3B556C4468CAQ35801509-92988B7F-A04D-4D9D-A8CC-68AE5DBFEEE7Q36294435-EFC3C090-B2B2-4CEA-83F4-278AF795CE91Q36630989-AFF29D70-5E13-468E-83FF-46FFE0022755Q37161551-AA98A704-0BF8-42C5-8A69-78C39D97F42FQ37291349-868E349F-B39D-4139-8349-554B555DB89AQ37304794-B541C1E4-DA18-4FBD-A74F-395247DEFFBEQ37735903-FD00F6E8-AA9E-44D9-A894-B719D0A57870Q37834186-CD2C37C7-4F62-40E7-88A8-66927EACE283Q38713411-0E2CA88A-D751-4D7E-A9AB-AB0C538C837BQ38893310-C21EB991-288A-467B-BA1A-513E47B020FDQ39027093-53AAA34D-D602-4D66-903E-2F80368F0171Q39686774-64F2965A-C3CF-4CEF-A133-66AB4A6014ECQ39894471-167E4FDA-A214-4A4C-BEC4-B57EB6238341Q39919691-34FF6344-61D6-4936-944A-583A881C4149Q41653852-B4F1EC1F-861A-4A92-877C-B8800CBE5287Q41915492-55E16E10-EE38-4B7A-B340-38673F29B529Q42048932-FE5774CE-841D-4B59-99CA-BC82E6180D8FQ42943407-3093730A-9655-4371-BFF1-626E5761B697Q42947069-CF6BE11C-716B-414C-8DC9-239443C224BEQ47150482-C6D5142A-BEC6-47A6-A268-2C5B6D76796BQ49485880-0B435341-7AF6-4297-A43E-04532B7521ECQ51010477-C09BADA4-A7D2-43AE-A9D4-1056497EE63BQ52661545-6714E435-15F8-4AF8-AE81-7A887C85A434Q53552462-CAC650F7-2C29-49F0-AA45-990D1AA9864AQ57821217-FF37530B-62C9-49FA-988F-34DA025B7D2C
P2860
Evolution of extended-spectrum beta-lactamases by mutation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evolution of extended-spectrum beta-lactamases by mutation.
@en
Evolution of extended-spectrum beta-lactamases by mutation.
@nl
type
label
Evolution of extended-spectrum beta-lactamases by mutation.
@en
Evolution of extended-spectrum beta-lactamases by mutation.
@nl
prefLabel
Evolution of extended-spectrum beta-lactamases by mutation.
@en
Evolution of extended-spectrum beta-lactamases by mutation.
@nl
P1476
Evolution of extended-spectrum beta-lactamases by mutation.
@en
P2093
Gniadkowski M
P356
10.1111/J.1469-0691.2007.01854.X
P478
14 Suppl 1
P577
2008-01-01T00:00:00Z